From transfer portal additions to position battles to how much NIL the Huskers had compared to other programs, Matt Rhule, ...

King's College London researchers have created a unique collection of human stem cell models that could help to uncover why ...

Treatment approaches have shifted with the introduction of targeted agents, notably Bruton tyrosine kinase (BTK) inhibitors, ...

Most social workers believe there are no meaningful career progression opportunities besides stepping into management, a poll ...

A population-based study from Sweden upends conventional thinking on when patients with mantle cell lymphoma (MCL) can exhale ...

Under the leadership of Abhishek Khaitan, managing director, Radico Khaitan, the core leadership team comprises Dilip ...

This section focuses on the clinical decision making process following progression on lanreotide and lutetium Lu 177 dotatate. Dr Shaheen outlines how she approaches next line therapy selection in a ...

Citi's 2026 Virtual Oncology Leadership Summit February 18, 2026 1:00 PM ESTCompany ParticipantsJoshua Bleharski - ...

Getting stronger isn't just reserved for lifting weights in the gym. In fact, it's entirely plausible to add muscle and develop power using minimal equipment without having to listen to the grunts of ...

Patients treated with ciltacabtagene autoleucel (cilta-cel; Carvykti) in the phase 3 CARTITUDE-4 trial (NCT04181827) achieved high rates of progression-free survival (PFS) at near ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the U.S. Food and Drug Administration (FDA) approved KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ ...

CEO Mark Goldsmith outlined the company’s late-stage plans for its RAS(ON) inhibitor daraxonrasib, discussed expansion into ...